Johnson & Johnson makes $15 billion bet on mental-health drugs
Pharma giant Johnson & Johnson is buying Intra-Cellular Therapies, eying sales growth above analysts’ expectations through 2029.
What's Your Reaction?







Chatty News Dec 7, 2024 0 39
Chatty News Nov 18, 2024 0 36
Chatty News Nov 26, 2024 0 32
Chatty News Dec 26, 2024 0 28
Chatty News Feb 18, 2025 0 27
Chatty News Nov 18, 2024 0 19
Chatty News Nov 18, 2024 0 21
Chatty News Nov 18, 2024 0 21
Total Vote: 5
Yes